Leafy Tunnel
Venture capitalLondon · Seed–Series A · 2 people tracked
Investment thesis
Leafy Tunnel focuses on backing companies developing alternative medicines aimed at addressing mental health issues and pain-related disorders. Its stated investment interest centers on therapeutic approaches in these areas.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's website
What they invest in
from 9 of 9 portfolio companiesBiotech ×6Mental Health ×4Deep Tech ×3Digital Health ×3Medical Devices ×3AI & Machine Learning ×2Healthtech ×2AgTech ×1
HQs:Canada×1Denmark×1
Investments · 9 tracked
founders shown can be your intro path
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)Christian Angermayer(Founder and Chairman of the Board)
Co-investorsAble PartnersAlpha Wave GlobalCatalio Capital Management, LPFJ LabsFuture VenturesNucleus Adventure Capital+3 more
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerSrinivas Rao
Co-investorsFJ LabsIter InvestmentsNoeticRedbus VenturesWhat If Ventures
IUVO is a cannabis company that partners with craft cultivators, including Organnicraft, a British Columbia-based grower of premium cannabis strains from the legacy markets of California and BC.
AgTechConsumer
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.
BiotechDeep TechMental Health
Co-investorsJourneyOne VenturesLauder PartnersSolari CapitalWGD Capital, L.P.
Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.
AI & Machine LearningDigital HealthHealthtech
Co-investorsInnovating CapitalPsyMed Ventures
Prohibition Partners is a B2B platform for the cannabis industry, offering market data and intelligence, digital media and publishing, events and conferences, and commerce technology.
B2B MarketplacesData & InfrastructureMedia & Entertainment
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.
BiotechDeep TechHealthtech
Matthew Baggott(CEO)
Co-investorsNoeticPsyMed Ventures
TETRAPHARM is a Danish biopharmaceutical company developing drugs targeting the central nervous system and immune system to treat neurological diseases and mental health disorders.
BiotechMedical DevicesMental HealthCopenhagen, DK
Exits · 1
IPOs and acquisitions across the tracked portfolioAtaiBeckleyNASDAQ: ATAI
Portfolio news
latest coverage across their companiesAtaiBeckley · investing.com · Jul 17, 2026
Beckley Psytech · wmbdradio.com · Jul 16, 2026
Principals & officers · per Companies House
what is this? ⓘNikolay Tretiyakov — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors
Frequently asked questions
- How many investments has Leafy Tunnel made?
- Leafy Tunnel has 9 tracked investments.
- What stage does Leafy Tunnel invest at?
- Leafy Tunnel invests at the Seed, Series A stages.
- What sectors does Leafy Tunnel focus on?
- Leafy Tunnel focuses on Biotech, Healthtech, Medical Devices, Mental Health, Wellness & Fitness.
- Where is Leafy Tunnel located?
- Leafy Tunnel is headquartered in London, GB.
- Who does Leafy Tunnel co-invest with?
- Leafy Tunnel most often shares deals with FJ Labs, Noetic, PsyMed Ventures, among 20 tracked co-investors.
Media · Podcasts & interviews
featuring the teamProfessionally Cannabis | Bek Muslimov & Nikolay Tretiyakov, Co-Founders of Leafy Tunnel | EP62
Global Cannabis Intelligence · Nikolay Tretiyakov
Similar investors
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
PsyMed Ventures is an early-stage venture firm investing in neuroscience and frontier technologies aimed at improving brain and mental health.